Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Oihana Mora-Atorrasagasti"'
Autor:
Olatz Ibarra-Barrueta, Oihana Mora-Atorrasagasti, Itziar Palacios-Zabalza, Urko Aguirre-Larracoechea, Maria Jose Legarreta, Nerea González-Hernández
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 8, Iss 1, Pp 1-12 (2024)
Abstract Background The aim of this study was to determine the psychometric properties of the Spanish-language version of the HIV-Symptom Index (HIV-SI) questionnaire in Spanish patients undergoing antiretroviral therapy. Methods Between 2014 and 201
Externí odkaz:
https://doaj.org/article/eff1eb76ecd64332a6575c438ae78ba9
Autor:
Ramón Morillo-Verdugo, Tamara Aguilar Pérez, Mercedes Gimeno-Gracia, Carmen Rodríguez-González, María de las Aguas Robustillo-Cortes, Aitziber Illaro Uranga, Alicia Lázaro López, Angels Andreu Crespo, Aránzazu Linares Alarcón, Beatriz Proy Vega, Belén López García, Carlos Seguí Solanes, Carolina Aguilar Guisado, Elena Cárdaba García, Emilio Molina Cuadrado, Emilio Monte Boquet, Encarna Abad Lecha, Esther Vicente Escrig, Gabriel Mercadal Orfila, Herminia Navarro Aznárez, Inmaculada Nacle López, Irene Cañamares Orbis, Jara Gallardo Anciano, Javier Casas Arrate, Javier Sánchez-Rubio Ferrández, Joaquín Ignacio Serrano López, José Alberto Peña Pedrosa, Jose Sebastián Roldan González, Luis Carlos Fernández Lisón, Luis Margusino Framinan, Luis Ortega Valín, Maite Martin, Manuel Vélez, María Ángeles Andreu Crespo, Maria Carmen Rosado Maria, María García Coronel, Maria Jose Huertas Fernández, Mercedes Manzano García, Noelia Garrido Peña, Oihana Mora Atorrasagasti, Patricia Sanmartin Fenollera, Pilar Díaz Ruíz, Ramón San Miguel Elcano, Raquel Fresquet Molina, Vera Áreas del Águila, Dr Elena Rebollo-Gómez, Dr Vanessa Marfil
Publikováno v:
The Annals of pharmacotherapy. 57(2)
Background People living with human immunodeficiency virus (HIV) require specific pharmaceutical care (PC). Although the 2017 Capacity-Motivation-Opportunity (CMO) PC model allows a multidisciplinary approach that focuses on patient needs, it is too
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6db55a4e1fc31086547812ddd86b5bdb
https://pubmed.ncbi.nlm.nih.gov/35707861
https://pubmed.ncbi.nlm.nih.gov/35707861
Autor:
Olatz, Ibarra-Barrueta, Oihana, Mora-Atorrasagasti, María José, Legarreta, Aitziber, Illaro-Uranga, Ramón, Morillo-Verdugo
Publikováno v:
Farmacia Hospitalaria, Vol 43, Iss 3, Pp 87-93 (2019)
The primary endpoint is to validate the HIV Symptoms Index Questionnaire in a Spanish population, in terms of comprehension and acceptability. The secondary endpoints are to describe symptoms reported by patients, tolerance, and quality of life.The p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::cdb390128275d239b12ff90ba2d221b4
http://www.aulamedica.es/fh/pdf/11127.pdf
http://www.aulamedica.es/fh/pdf/11127.pdf
Publikováno v:
The Annals of pharmacotherapy. 48(1)
Objective: To report the case of an HIV patient who developed neuropsychiatric disturbances when montelukast was added to her therapy containing efavirenz. Case Summary: A 41-year-old woman with HIV infection had been on treatment with efavirenz, emt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba1d47afd600f29cb1c5f70473909d01
https://pubmed.ncbi.nlm.nih.gov/24259633
https://pubmed.ncbi.nlm.nih.gov/24259633